Finally had a chance to go through the presentation.
The good;- FY 25 guidance unchanged. Although net income guidance range is between $630m-$700m which could produce a big miss if JHX achieve on the lower end of guidance.
- Slight increase in gross margins.
The bad;
- Second quarter advised to be challenging despite Q2 apparently being a normally strong quarter (according to analysts at Jefferies).
- Slight decrease in EBIT margins.
- Growth is low single digits in some metrics, and declining in others.
I think it was a solid report considering all the macro, but I think the cautious outlook statement hasn't filled many with confidence. I thought I missed the opportunity to buy ~6 weeks ago when JHX jumped up to $55, but I think it will still linger around this price. An interest rate cut or two in the US will probably boost JHX slightly.
Did you end up buying some more
@pastperformer ?
I think i'd be more comfortable jumping in at the low $40's, will it get there? who knows.
(20min delay)